Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo
PROSPECTIVE RANDOMIZED 12-WEEK CONTROLLED STUDY OF VISUAL FIELD CHANGE IN SUBJECTS WITH PARTIAL SEIZURES RECEIVING PREGABALIN OR PLACEBO
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Listed as NCT00351611, this PHASE4 trial focuses on Epilepsies, Partial and remains completed. Sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris Inc., it has been updated 37 times since 2006, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
37 versions recorded-
Jan 2026 — Present [monthly]
Completed PHASE4
-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
May 2021 — Jul 2024 [monthly]
Completed PHASE4
▶ Show 32 earlier versions
-
Mar 2021 — May 2021 [monthly]
Completed PHASE4
-
Feb 2021 — Mar 2021 [monthly]
Completed PHASE4
-
Jan 2021 — Feb 2021 [monthly]
Completed PHASE4
-
Dec 2020 — Jan 2021 [monthly]
Completed PHASE4
-
Nov 2020 — Dec 2020 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Jul 2020 — Nov 2020 [monthly]
Recruiting PHASE4
-
May 2020 — Jul 2020 [monthly]
Recruiting PHASE4
-
Feb 2020 — May 2020 [monthly]
Recruiting PHASE4
-
Jan 2020 — Feb 2020 [monthly]
Recruiting PHASE4
-
Nov 2019 — Jan 2020 [monthly]
Recruiting PHASE4
-
Oct 2019 — Nov 2019 [monthly]
Recruiting PHASE4
-
Sep 2019 — Oct 2019 [monthly]
Recruiting PHASE4
-
Jul 2019 — Sep 2019 [monthly]
Recruiting PHASE4
-
Jun 2019 — Jul 2019 [monthly]
Recruiting PHASE4
-
May 2019 — Jun 2019 [monthly]
Recruiting PHASE4
-
Apr 2019 — May 2019 [monthly]
Recruiting PHASE4
-
Mar 2019 — Apr 2019 [monthly]
Recruiting PHASE4
-
Oct 2018 — Mar 2019 [monthly]
Recruiting PHASE4
-
Aug 2018 — Oct 2018 [monthly]
Recruiting PHASE4
-
Jul 2018 — Aug 2018 [monthly]
Recruiting PHASE4
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE4
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE4
-
Mar 2018 — May 2018 [monthly]
Recruiting PHASE4
-
Feb 2018 — Mar 2018 [monthly]
Recruiting PHASE4
-
Dec 2017 — Feb 2018 [monthly]
Recruiting PHASE4
-
Nov 2017 — Dec 2017 [monthly]
Recruiting PHASE4
-
Oct 2017 — Nov 2017 [monthly]
Recruiting PHASE4
-
Jun 2017 — Oct 2017 [monthly]
Recruiting PHASE4
-
May 2017 — Jun 2017 [monthly]
Recruiting PHASE4
-
Apr 2017 — May 2017 [monthly]
Recruiting PHASE4
-
Feb 2017 — Apr 2017 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Jul 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
For direct contact, visit the study record on ClinicalTrials.gov .